Lan Zhu Zhiliang Guo Daqiang Zhao Rula Sa Guangyuan Zhao Hui Guo Gang Chen
10.3389/fimmu.2022.1087597
Front Immunol
2023 Jan 11;13:1087597.
hla-dq case report chronic active antibody-mediated rejection daratumumab donor specific antibodies kidney transplantation
CC BY
https://pubmed.ncbi.nlm.nih.gov/36713391/
Kidney Transplantation / adverse effects
Kidney Transplantation / adverse effects Case Reports Research Support, Non-U.S. Gov't Allografts Antibodies, Monoclonal / therapeutic use Graft Rejection Humans Immunoglobulins, Intravenous Isoantibodies Kidney / physiology daratumumab Immunoglobulins, Intravenous Isoantibodies Antibodies, Monoclonal
PMC9875042
36713391
Case report: Daratumumab for treatment of refractory late or chronic active antibody-mediated rejection in renal allograft recipients with high levels of de novo donor-specific antibodies
2023